Impact of implementing smart infusion pumps in a pediatric intensive care unit

American Journal of Health-System Pharmacy

Volumn 70, Issue 21, 2013, Pages 1897-1906

  Manrique Rodríguez, Silvia ^a   Sánchez Galindo, Amelia C ^a   López Herce, Jesús ^a   Calleja Hernández, Miguel Ángel ^b   Martínez Martínez, Fernando ^c   Iglesias Peinado, Irene ^d   Carrillo Álvarez, Ángel ^a   Sanjurjo Sáez, María ^a   Fernández Llamazares, Cecilia M ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^c Faculty of Pharmacy   (Spain)

^d UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ADRENERGIC RECEPTOR STIMULATING AGENT; ANALGESIC AGENT; ANESTHETIC AGENT; ANTIARRHYTHMIC AGENT; INOTROPIC AGENT; INSULIN; NARCOTIC AGENT; OPIATE; POTASSIUM; SEDATIVE AGENT; TEICOPLANIN; VANCOMYCIN; DRUG;

ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; HUMAN; INFUSION PUMP; INFUSION RATE; INTENSIVE CARE UNIT; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MEDICATION ERROR; OBSERVATIONAL STUDY; PATIENT SAFETY; PRACTICE GUIDELINE; PROSPECTIVE STUDY; SMART INFUSION PUMP; SYRINGE; CHILD; INTRAVENOUS DRUG ADMINISTRATION; PILOT STUDY; SEVERITY OF ILLNESS INDEX; SPAIN; STATISTICS;

CHILD; GUIDELINE ADHERENCE; HUMANS; INFUSION PUMPS; INFUSIONS, INTRAVENOUS; INTENSIVE CARE UNITS, PEDIATRIC; MEDICATION ERRORS; PHARMACEUTICAL PREPARATIONS; PILOT PROJECTS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SOFTWARE; SPAIN;

EID: 84901736942     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp120767     Document Type: Article

References (36)

1. Leape LL, Bates DW, Cullen DJ et al. Systems analysis of adverse drug events. ADE Prevention Study Group. JAMA. 1995; 274:35-43.
2. Pepper GA. Errors in drug administration by nurses. Am J Health-Syst Pharm. 1995; 52:390-5.
3. National Coordinating Council for Medication Error Reporting and Prevention. NCCMERP taxonomy of medication errors. www.nccmerp.org/aboutMed Errors.html (accessed 2012 Feb 4).
4. Kaushal R, Bates DW, Landrigan C et al. Medication errors and adverse drug events in pediatric inpatients. JAMA. 2001; 285:2114-20.
5. Gazarian M, Graudins LV. Long-term reduction in adverse drug events: an evidence-based improvement model. Pediatrics. 2012; 129:e1334-42.
6. Hadaway LC. Managing i.v. therapy: "high-alert" drugs keep nurse managers ever watchful. Nurs Manage. 2000; 31(10):38-40.
7. Verklan MT. Malpractice and the neonatal intensive-care nurse. J Obstet Gynecol Neonatal Nurs. 2004; 33:116-23.
8. Sullivan JE, Buchino JJ. Medication errors in pediatrics - the octopus evading defeat. J Surg Oncol. 2004; 88:182-8.
9. Serious reportable events in patient safety: a National Quality Forum consensus report. Washington, DC: National Quality Forum; 2002.
10. Fernández-Llamazares CM, Calleja-Hernández MA, Manrique-Rodríguez S et al. Impact of clinical pharmacist interventions in reducing paediatric prescribing errors. Arch Dis Child. 2012; 97:564-8.
11. Rothschild JM, Keohane CA, Thompson S et al. Intelligent intravenous infusion pumps to improve medication administration safety. AMIA Annu Symp Proc. 2003:992.
12. Giannopoulos HT. Smart pump technology. In: Dumitru D, ed. The pharmacy informatics primer. Bethesda, MD: American Society of Health-System Pharmacists; 2008:119-27.
13. Institute for Safe Medication Practices. Proceedings from the ISMP summit on the use of smart infusion pumps. Guidelines for safe implementation and use. www.ismp.org/Tools/guidelines/smartpumps/comments/default.asp (accessed 2012 Apr 16).
14. Ontario Health Technology Advisory Committee. OHTAC recommendation: implementation and use of smart medication delivery systems, July 2009. www.health.gov.on.ca/english/providers/program/ohtac/tech/recommend/rec-smd-20090701.pdf (accessed 2013 Jun 26).
15. Healthcare Human Factors Group. Smart medication delivery systems: infusion pumps. Toronto: University Health Network; 2009.
16. Healthcare Human Factors Group. Smart medication delivery systems: infusion pumps. Supplementary report: evaluation of effective smart pump design and education strategies. Toronto: University Health Network; 2010.
17. Manrique-Rodríguez S, Sánchez-Galindo A, Fernández-Llamazares CM et al. Developing a drug library for smart pumps in a pediatric intensive care unit. Artif Intell Med. 2012; 54(3):155-61.
18. Manrique-Rodríguez S, Sánchez-Galindo A, Fernández-Llamazares CM et al. Smart pump alerts: all that glitters is not gold. Int J Med Inform. 2012; 81:344-50.
19. Otero Lopez MJ, Castano Rodriguez B, Perez Encinas M et al. [Updated classification for medication errors by the Ruiz-Jarabo 2000 Group.] Farm Hosp. 2008; 32(1):38-52. In Spanish.
20. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977; 33:159-74.
21. ISMP Spain. [List of high-risk medications, 2008.] www.ismp-espana.org/estaticos/view/39 (accessed 2012 Feb 19). In Spanish.
22. Echarri L, Fernández-Llamazares CM, Manrique S et al. Evaluación de los errores de administración de medicamentos en una unidad de cuidados intensivos pediátricos. In: Libro de ponencias: I jornada de investigación del Instituto de Investigación Sanitaria Hospital Gregorio Marañón. Madrid: Hospital General Universitario Gregorio Marañón; 2011:66. In Spanish.
23. Breland BD. Continuous quality improvement using intelligent infusion pump data analysis. Am J Health-Syst Pharm. 2010; 67:1446-55.
24. Dusing Wiest M, Longshore L, Harger N. Implementation of intelligent infusion technology in a multihospital setting. Am J Health-Syst Pharm. 2010; 67:878-83.
25. Fanikos J, Fiumara K, Baroletti S et al. Impact of smart infusion technology on administration of anticoagulants (unfractionated heparin, argatroban, lepirudin, and bivalirudin). Am J Cardiol. 2007; 99:1002-5.
26. Rothschild JM, Keohane CA, Cook EF et al. A controlled trial of smart infusion pumps to improve medication safety in critically ill patients. Crit Care Med. 2005; 33:533-40.
27. Husch M, Sullivan C, Rooney D et al. Insights from the sharp end of intravenous medication errors: implications for infusion pump technology. Qual Saf Health Care. 2005; 14:80-6.
28. Nuckols TK, Bower AG, Paddock SM et al. Programmable infusion pumps in ICUs: an analysis of corresponding adverse drug events. J Gen Intern Med. 2008; 23(suppl 1):41-5.
29. Naranjo CA, Busto U, Sellers EM et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30:239-45.
30. Taxis K, Dean B, Barber N. The validation of an existing method of scoring the severity of medication administration errors for use in Germany. Pharm World Sci. 2002; 24:236-9.
31. Dean BS, Barber ND. A validated, reliable method of scoring the severity of medication errors. Am J Health-Syst Pharm. 1999; 56:57-62.
32. Kopp BJ, Mrsan M, Erstad BL et al. Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist. Am J Health-Syst Pharm. 2007; 64:2483-7.
33. Hatoum HT, Catizone C, Hutchinson RA et al. An eleven-year review of the pharmacy literature: documentation of the value and acceptance of clinical pharmacy. Drug Intell Clin Pharm. 1986; 20:33-48.
34. Overhage JM, Lukes A. Practical, reliable, comprehensive method for characterizing pharmacists' clinical activities. Am J Health-Syst Pharm. 1999; 56:2444-50.
35. Sakowski J, Newman JM, Dozier K. Severity of medication administration errors detected by a bar-code medication administration system. Am J Health-Syst Pharm. 2008; 65:1661-6.
36. Folli HL, Poole RL, Benitz WE et al. Medication error prevention by clinical pharmacists in two children's hospitals. Pediatrics. 1987; 79:718-22.